Associate Professor Angela Devine

Principal Research Fellow

Qualifications:

PhD, The Open University, 2018; Master of Science, London School of Hygiene and Tropical Medicine, 2008; Bachelor of Science, University of Evansville, 2006

Approved level of HDR supervision at Charles Darwin University:

Principal supervisor

Location:

Melbourne

Biography:

Angela Devine is a health economist with over 15 years of experience in the economic evaluation and costs related to the management of infectious diseases. Since joining Menzies in 2018, she has helped to secure over $38 million in competitive grant funding, including an NHMRC Ideas grant on multi-species malaria modelling as CIA. She also holds an NHMRC Emerging Leadership Fellowship. 


Dr Devine’s primary research interest is in providing policy-relevant economic evidence on the control and treatment of malaria. Her broader interests in infectious diseases extend from malaria to HIV, tuberculosis, hepatitis B, antimicrobial resistance, and dengue. Methodological research interests include the joint costs and consequences of co-infections, the measurement and valuation of productivity losses, and the development of online tools to address policy decisions. Available online tools can be found here and here.


She leads the health economics stream within the malaria team as well as the Health Economics Group at Menzies. In addition to her role at Menzies, she holds a position at The University of Melbourne, where she is Deputy Head of the Economics of Global Health and Infectious Diseases Unit. In addition, she is an Academic Editor for PLOS Global Public Health and is a Committee Member for Women in Global Health (WGH) Australia.


Her ORCID profile can be found here.

Associate Professor Angela Devine
Email
Research Themes
  1. MEDIA RELEASE | Menzies researchers RESPOND to priority diseases in our global neighbourhood
  2. MEDIA RELEASE | Is tafenoquine a cost-effective treatment option for Plasmodium vivax malaria?
  3. MEDIA RELEASE | Five Menzies researchers awarded NHMRC Investigator Grants
  4. Global costs of Plasmodium vivax malaria estimated for the first time.
  5. First study to estimate the global costs due to vivax malaria
  6. MEDIA RELEASE | First study to estimate the global costs due to vivax malaria
  7. New study shows faster way to cure vivax malaria
  8. 7th International Conference on Plasmodium vivax Research | Final Report
  9. Coverage from the 7th International Conference on Plasmodium vivax Research
  1. Price, D.J., Nekkab, N., Monteiro, W.M., Villela, D.A.M., Simpson, J.A., Lacerda, M.V.G., White, M., Devine, A. (2024) The cost-effectiveness of tafenoquine following G6PD screening for the treatment of vivax malaria in Brazil: a transmission model analysis. PLOS Medicine; 21(1): e1004255. doi: https://doi.org/10.1371/journal.pmed.1004255
  2. Walker, C.R., Hickson, R.I., Chang, E., Ngor, P., Sovannaroth, S., Simpson, J.A., Price, D.J., McCaw, J.M., Price, R.N., Flegg, J., Devine, A. (2023) A model for malaria treatment evaluation in the presence of multiple species. Epidemics; 44: 100687. doi: https://doi.org/10.1016/j.epidem.2023.100687 
  3. Devine, A., Xiong, X., Gottlieb, S.L., Britto de Mello, M., Fairley, C.K., Ong, J.J. (2022) Health-related quality of life in individuals with genital herpes: a systematic review. Health Qual Life Outcomes; 20(1):25. doi: https://doi.org/10.1186/s12955-022-01934-w
  4. Akpan, E., Hossain, S.J., Devine, A., Braat, S., Hamadani, J.D., Pasricha, S.R., Carvalho, N. (2022) Cost-effectiveness of universal iron supplementation and iron-containing micronutrient powders for anaemia among young children in rural Bangladesh. Am J Clin Nutr, 116(5):1303–1313. doi: https://doi.org/10.1093/ajcn/nqac225
  5. Devine, A., Battle, K.E., Meagher, N., Howes, R.E., Dini, S., Gething, P., Simpson, J.A., Price, R.N., Lubell, Y. (2021). Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study. PLoS Medicine, 18(6): e1003614. doi: https://doi.org/10.1371/journal.pmed.1003614
  6. Agius, P.A., Cutts, J.C., Oo, W.H., Thi, A., O'Flaherty, K., Aung, K.Z., Thu, H.K., Aung, P.P., Thein, M.M., Zaw, N.N., Htay, W.Y.M., Soe, A.P.,  Razook, Z., Barry, A.E., Htike, W, Devine, A,. Simpson, J.A., Crabb, B.S., Beeson, J.G., Pasricha, N., Fowkes, F.J.I. (2020). Evaluation of the effectiveness of topical repellent distributed by village health volunteer networks against Plasmodium spp. infection in Myanmar: a stepped-wedge cluster randomised trial. PLOS Medicine; 17(8): e1003177. doi: https://doi.org/10.1371/journal.pmed.1003177
  7. Devine, A., Pasaribu, A. P., Teferi, T., Pham, H. T., Awab, G. R., Contantia, F., . . . Lubell, Y. (2019). Provider and household costs of Plasmodium vivax malaria episodes: a multicountry comparative analysis of primary trial data. Bull World Health Organ, 97(12), 828-836. doi: https://doi.org/10.2471%2FBLT.18.226688 
  8. Taylor, W. R. J., Thriemer, K., von Seidlein, L., Yuentrakul, P., Assawariyathipat, T., Assefa, A., . . . Price, R. N. (2019). Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial. Lancet, 394(10202), 929-938. doi: https://doi.org/10.1016/S0140-6736(19)31285-1
  9. Devine, A., Parmiter, M., Chu, C. S., Bancone, G., Nosten, F., Price, R. N., . . . Yeung, S. (2017). Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis. PLOS Negl Trop Dis, 11(5), e0005602. doi: https://doi.org/10.1371/journal.pntd.0005602 
  10. Drake, T. L., Devine, A., Yeung, S., Day, N. P., White, L. J., & Lubell, Y. (2016). Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review. Health Econ, 25 Suppl 1, 124-139. doi: https://doi.org/10.1002/hec.3303